Abstract:Botulinum neurotoxins (BoNTs) are one of the most toxic proteins known to humans. Their molecular structure is comprised of three essential domains—a cell binding domain (HC), translocation domain and catalytic domain (light chain) . The HC domain facilitates the highly specific binding of BoNTs to the neuronal membrane via a dual‐receptor complex involving a protein receptor and a ganglioside. Variation in activity/toxicity across subtypes of serotype A has been attributed to changes in protein and gangliosid… Show more
“…Previously, we and others have determined the crystal structures of the binding domains from BoNT subtypes /A1, /A2, /A3 and /A4, and the related /HA alone [13][14][15][16][17], and in complex with various receptors: H C /A1-GT1b [18], H C /A1-SV2C [19,20], H C /A2-SV2C [14,21] and H C /A3-GD1a [22]. Here, we report the crystal structures of the BoNT/A5 and BoNT/A6 receptor-binding domain and compare the binding sites with previous crystal structures of the BoNT/A subtype.…”
Botulinum neurotoxins (BoNTs) cause the deadly condition called botulism, but they can be used as therapeutics for a wide range of indications. BoNTs are classified into many different serotypes and subtypes, each with potentially different intoxication properties. Here, we report crystal structures of the receptor‐binding domains from two subtypes (BoNT/A5 and BoNT/A6) and compare their binding sites with previous BoNT/A structures.
“…Previously, we and others have determined the crystal structures of the binding domains from BoNT subtypes /A1, /A2, /A3 and /A4, and the related /HA alone [13][14][15][16][17], and in complex with various receptors: H C /A1-GT1b [18], H C /A1-SV2C [19,20], H C /A2-SV2C [14,21] and H C /A3-GD1a [22]. Here, we report the crystal structures of the BoNT/A5 and BoNT/A6 receptor-binding domain and compare the binding sites with previous crystal structures of the BoNT/A subtype.…”
Botulinum neurotoxins (BoNTs) cause the deadly condition called botulism, but they can be used as therapeutics for a wide range of indications. BoNTs are classified into many different serotypes and subtypes, each with potentially different intoxication properties. Here, we report crystal structures of the receptor‐binding domains from two subtypes (BoNT/A5 and BoNT/A6) and compare their binding sites with previous BoNT/A structures.
“…A total of nine hydrogen bonding interactions were present between H C /A4 and GD1a (Figure 1B) (Table 2)-there was clear electron density for the two terminal nitrogen atoms of Arg 1282 which interact with Sia 5 and Gln 1276. [23]) and H C /A1:GD1a (PDB: 5TPC [22]). Watermediated interactions are indicated by a "-H 2 O molecule (n 1 , n 2 )" where n 1 is the distance between the amino acid residue and the water, and n 2 is the distance between the water and monosaccharide.…”
Section: Structure Of H C /A4 In Complex With Gd1a Oligosaccharidementioning
confidence: 99%
“…∆ Indicates they are the equivalent water molecule for each structure. Data adapted from [23]. The crystal packing of HC/A4 changes significantly upon binding of GD1a as evidenced by the change in both unit cell dimensions and space group.…”
Section: Structure Of H C /A4 In Complex With Gd1a Oligosaccharidementioning
confidence: 99%
“…Gangliosides are glycosphingolipids that are often involved in cellular-signalling pathways and are comprised of a membrane anchored hydrophilic lipid tail, and an extracellular oligosaccharide moiety [21]. Previous studies have reported the structures of the binding domain of BoNT/A1 (H C /A1) and BoNT/A3 (H C /A3) in complex with the receptor ganglioside GD1a [22,23], detailing the interactions that occur between the two. These structures reveal that the ganglioside binding site (GBS) is formed by a β-hairpin and loop in the C-terminal subdomain of H C (H CC ).…”
Botulinum neurotoxins (BoNT) cause the potentially fatal neuroparalytic disease botulism that arises due to proteolysis of a SNARE protein. Each BoNT is comprised of three domains: a cell binding domain (HC), a translocation domain (HN), and a catalytic (Zn2+ endopeptidase) domain (LC). The HC is responsible for neuronal specificity by targeting both a protein and ganglioside receptor at the neuromuscular junction. Although highly toxic, some BoNTs are commercially available as therapeutics for the treatment of a range of neuromuscular conditions. Here we present the crystal structures of two BoNT cell binding domains, HC/A4 and HC/A5, in a complex with the oligosaccharide of ganglioside, GD1a and GM1b, respectively. These structures, along with a detailed comparison with the previously reported apo-structures, reveal the conformational changes that occur upon ganglioside binding and the interactions involved.
“…This article was the subject of our first commentary article [2], and we hope to commission commentaries to accompany other papers of especial significance in the future. Other exciting work across the molecular and cellular life sciences published in FEBS Open Bio this year includes a report of alterations in neuronal development in a mouse model of Timothy syndrome [3], the crystal structure of botulinum neurotoxin subtype A3 cell‐binding domain in complex with the ganglioside GD1a [4], engineered variants of tobacco etch virus protease with enhanced enzymatic activity [5], the discovery that autologous apoptotic neutrophils inhibit inflammatory secretion by dendritic cells [6] and the use of fluorescence microscopy to reveal cooperative binding of cardiac troponin and tropomyosin to filamentous actin [7]. These are but a few of the fascinating studies published this year in the journal.…”
In this Editorial, the Editor‐in‐Chief Professor Miguel A. De la Rosa discusses the performance and development of FEBS Open Bio in 2020 and outlines his plans for the journal in 2021.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.